<div id="readability-page-1"><article>New digital platform combines an 8-week Success Blueprint, Dr. Smith AI Wellness Coach, AI Agent-powered community support, and AI-powered Lifetime Wellness Mode to help users stay consistent beyond motivation ROCK HILL, S.C.--(BUSINESS WIRE)--Vynleads (OTCQB: VYND) today announced the official launch of the Done With Diabetes™ app, a mobile-first digital wellness platform designed to help adults with type 2 diabetes, prediabetes, and metabolic health goals build sustainable lifestyle routines through clear daily structure, personalized guidance, and AI-powered wellness coaching.<img src="https://imageproxy.pbkrs.com/https://mms.businesswire.com/media/20260211919103/en/2718397/4/vynleads-done-with-diabetes-app-launch-ai-coach-blood-sugar-metabolic-health_copy.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://mms.businesswire.com/media/20260211919103/en/2718397/4/vynleads-done-with-diabetes-app-launch-ai-coach-blood-sugar-metabolic-health_copy.jpg"/>For millions of people, diabetes is managed during brief clinical visits, yet outcomes are shaped by hundreds of daily decisions made at home, at work, and in everyday life. Done With Diabetes™ was built to close that gap by translating lifestyle medicine principles into a simple, repeatable day-by-day experience.&#34;We designed this platform for the reality of diabetes—it’s managed day by day,” said Alex Mannine, Co-Founder and CEO of Vynleads. “Done With Diabetes™ gives people a clear plan they can follow, with personalized guidance that adapts as they build momentum, plus a Community supported by AI Agents and peers so no one feels alone between appointments. The goal is simple: make progress sustainable.”What Users Get Inside the Done With Diabetes™ AppThe Done With Diabetes™ app is built around Vynleads’ proprietary Lifestyle Blueprint™. This AI-powered personalization engine aligns the program experience to each user’s goals, habits, and constraints. The result is a structured diabetes lifestyle routine that is designed to be used daily, not occasionally.<ul><li>Lifestyle Blueprint™ Personalization: Tailors daily targets, habits, and focus areas, and continues adapting based on the user’s responses and actions throughout the 8-week program and into Vynleads’ Lifetime Wellness Mode to prevent habit regression.</li><li>8-week Success Blueprint: A structured 56-day journey with phased modules (Foundation, Meal Plan, Lifestyle, Control) designed to build skills and routines progressively without the “you’re behind” pressure.</li><li>Dr. Smith AI Wellness Coach: Context-aware coaching that understands where a user is in the program and can help with meal swaps, real-world planning, motivation, and educational Q&amp;A within clear wellness guardrails.</li><li>Diabetes-Friendly Meal Planning: A curated library of 43+ lower-calorie recipes with full nutrition data, shopping lists, and practical guidance to reduce decision fatigue.</li><li>Progress Tracking: Easy-to-use dashboards for lifestyle metrics such as energy, stress, sleep, hydration, movement, and habit completion, so progress stays visible.</li><li>Engagement Designed for Consistency: Points, streaks, a Daily Spin, leaderboards, and a Wellness Garden that visually reflects consistency and is specifically built to reinforce adherence over time.</li><li>Community Support and Accountability: Forums, victory sharing, weekly/monthly challenges, buddy matching, and mentorship pathways, plus AI Agents that respond to user posts and questions to help keep the community active, supportive, and welcoming.</li></ul>AI Coaching and AI-Enhanced Community, Designed to Support Real LifeDr. Smith functions as an always-available wellness coach who helps users turn education into action in the moments that matter, whether planning meals, navigating setbacks, or maintaining consistency when motivation declines. In the app’s Community section, a set of AI Agents can respond to questions, encourage progress, and point users to relevant lessons, daily missions, recipes, and challenges aligned with where they are in the program. These Agents also respond to one another to surface helpful perspectives and keep conversations moving within clear wellness-only guardrails, and with transparency controls so users can tailor how they engage.AI-Powered Lifetime Wellness Mode: Support Beyond the First 8 WeeksAfter the initial 56-day Success Blueprint, users transition into the AI-powered Lifetime Wellness Mode, an ongoing support experience designed for maintenance, relapse prevention, and long-term consistency. Instead of defaulting to generic recommendations, the app draws on each user’s responses and actions throughout the program, including onboarding inputs, mission completion, check-ins, and overall engagement.It then uses that data to personalize what comes next, from weekly focus areas and post-graduation tasks to recommended missions, recipes, and challenges. The result is a frictionless continuation that keeps guidance relevant and actionable, helping reduce the “what now?” drop-off that often follows short-term programs.A Scalable Digital Wellness Platform with a Subscription ModelFor stakeholders, the launch represents a milestone in Vynleads’ evolution into a technology-enabled wellness platform. The Done With Diabetes™ app is launching as a subscription model—including a 7-day free trial and a $29/month subscription—designed to support recurring revenue while maintaining broad accessibility. The platform’s engagement loops (coaching, community, gamification, and post-graduation support) are intended to improve retention and lifetime value over time.Vynleads’ long-term vision is to build an expanding “Done With (DWX)” family of condition-aware lifestyle programs on a single platform, leveraging the same Lifestyle Blueprint™ engine, AI coaching, and community framework to address additional lifestyle-driven health challenges. In parallel with the direct-to-consumer rollout, Vynleads plans to expand Done With Diabetes™ availability for enterprise partners that include self-insured employers, health plans and payers, healthcare systems and provider groups, and pharmacy benefit managers seeking scalable metabolic health support for the individuals they serve.Important NoticeDone With Diabetes™ and the Done With Diabetes™ app are intended for general wellness and educational purposes only and are not intended to diagnose, treat, cure, or prevent any disease. Users should consult a qualified healthcare professional regarding any medical condition and before making changes to medications, diet, or exercise routines.About VynleadsVynleads (OTCQB: VYND) is a wellness company focused on lifestyle-first programs designed to help consumers address chronic, lifestyle-driven health challenges. Beginning with Done With Diabetes™, the Company’s vision is to develop a portfolio of “Done With (DWX)” offerings that combine evidence-informed content, structured behavior change, and technology-enabled support. For more information, visit www.vynleads.com.Forward-Looking StatementsThis press release contains forward-looking statements made within the meaning of the Private Securities Litigation Reform Act of 1995 by Vynleads and its representatives. These statements can be identified by introductory words such as “expects,” “plans,” “intends,” “believes,” “will,” “estimates,” “forecasts,” “projects,” or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing potential product applications, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not. Known risks and uncertainties include those identified from time to time in reports filed by Vynleads with the Securities and Exchange Commission. No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements. Vynleads undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.<img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjAyMTE5MTkxMDNyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjAyMTE5MTkxMDNyMQ"/>View source version on businesswire.com: https://www.businesswire.com/news/home/20260211919103/en/Media Contact Nick Mitsis Percepture nmitsis@percepture.comSource: Vynleads</article></div>

SBIO

Vynleads (OTCQB: VYND) has launched the Done With Diabetes™ app, a digital wellness platform aimed at helping adults manage type 2 diabetes and metabolic health. The app features an 8-week Success Blueprint, AI wellness coaching, personalized lifestyle routines, and community support. It operates on a subscription model, offering a 7-day free trial and aims to provide ongoing support through its AI-powered Lifetime Wellness Mode. This launch marks a significant step in Vynleads' evolution into a technology-enabled wellness platform, with plans for future expansion into other health challenges.

StockTitan

iShares US Pharma

ALPS Medical Breakthrough

Invesco Biotechnology & Genome ETF

VYNE Therapeutics

Health Care Select Sector SPDR

iShares Biotechnology ETF

Proshares Ultra Nasdaq Biotech

VG Health

iShares Global Healthcare

SPDR S&P Biotech

First Trust NYSE Arca Biotech Index Fd

Ark Genomic Revolution ETF

VanEck Biotech ETF

Vynleads (OTCQB: VYND) Launches Done With Diabetes™ App, Bringing AI-Powered Daily Lifestyle Support to Blood Sugar and Metabolic Health | VYND Stock News